Adaptive Biotechnologies Corporation / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €405.88M +21.6% -€28.09M +87.9% -6.9% -0.024 pp N/A N/A
    (estimated) €333.68M +18.1% -€14.95M -70.2% -4.5% +0.13 pp €74.95M +219.4% 22.5% +0.14 pp
    (estimated) €282.43M +21.9% -€50.11M -38.7% -17.7% +0.18 pp €23.47M -1,482.7% 8.3% +0.090 pp
    (estimated) €231.71M +14.0% -€81.71M -11.1% -35.3% +0.10 pp -€1.70M -86.6% -0.7% +0.055 pp
    (estimated) €203.17M +31.8% -€91.90M -33.1% -45.2% +0.44 pp -€12.64M -84.0% -6.2% +0.45 pp
    €154.18M +5.1% -€137.41M -29.2% -89.1% +0.43 pp -€78.87M -37.1% -51.2% +0.34 pp
    €146.70M -8.1% -€194.06M +58.1% -132.3% -0.55 pp -€125.46M -13.1% -85.5% +0.049 pp
    €159.65M +20.1% -€122.74M -30.7% -76.9% +0.56 pp -€144.39M +28.0% -90.4% -0.056 pp
    €132.97M +56.9% -€177.14M +47.2% -133.2% +0.087 pp -€112.85M +0.1% -84.9% +0.48 pp
    €84.76M +15.6% -€120.30M +137.4% -141.9% -0.73 pp -€112.76M -160.4% -133.0% -3.9 pp
    €73.29M +52.8% -€50.68M +26.6% -69.1% +0.14 pp €186.61M -935.0% 254.6% +3.0 pp
    €47.96M +44.8% -€40.02M +8.4% -83.4% +0.28 pp -€22.35M -19.8% -46.6% +0.38 pp
    €33.12M -€36.90M -111.4% -€27.87M -84.1%

    Notifications